My Speaker List

Jennifer Doudna on the Pandemic Year: The Power of Mission Driven Science

Amidst a year filled with tragedy, camaraderie and collaboration enabled scientific innovation to move society forward. Biochemist and Nobel Prize winner Jennifer Doudna reflects on how a team of professors, researchers, volunteers and engineers pushed through physical and technical barriers to create and administer a PCR-Covid-19 test.

“My hope as we climb out of this pandemic is that we build on this cooperation, increase funding for the type of fundamental science that made our work possible, and take a science-first leadership approach to stay ahead of future threats and safeguard our health.”

Jennifer Doudna, biochemist at UC Berkeley, Founder of the Innovative Genomics Institute, and 2020 Nobel Laureate for co-inventing of CRISPR technology

Read the full op-ed in the The Wall Street Journal.

Read More

After the Nobel, What Next for CRISPR Gene-editing Therapies?

CRISPR
CRISPR has transformed the possibilities for curing diseases caused by one or several genetic mutations. Clinical trials for therapies that utilize the genome editing technology are already underway for debilitating conditions such as sickle-cell anaemia, delivering treatments in disease areas where none currently exist.

Jennifer Doudna wins 2020 Nobel Prize

Awards , CRISPR
Innovative Genomics Institute founder and University of California, Berkeley, biochemist Jennifer Doudna today won the 2020 Nobel Prize in Chemistry with collaborator Emmanuelle Charpentier for their co-development of CRISPR-Cas9, a genome editing breakthrough that allows scientists to rewrite DNA, the code of life.